Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
LIMES Schlosskliniken AG operates private clinics specializing in the treatment of stress-related illnesses, mental, and emotional disorders, including depression, affective disorders, and acute burnout conditions. The company offers services primarily to private patients, those entitled to subsidies, and self-payers. Headquartered in Cologne, Germany, LIMES Schlosskliniken has expanded its geographic footprint through acquisitions, such as a 51% stake in Liechtenstein's Clinicum Alpinum AG in 2023, and increasing its stake in Switzerland's PRC Group AG to 56% in the same year. (,) In June 2025, the company opened LIMES Schlossklinik Abtsee, a specialized clinic for young adults aged 14 to 21, located near Salzburg, Austria. This strategic expansion enhances the company's service offerings and international presence.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
LIMES Schlosskliniken AGEli Lilly
Last price
€525.00$1,273.46
Currency
EUR
USD
€156M$1.2T
28.6443.86
€18.33$29.79
0.880.45
€10.00$6.69
1.90%0.53%
Sector
HealthHealth
Employees
31450,000
Ticker
€LIK$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €LIK or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.